CRP and lymphopenia: There was a linear trend between COVID-19 severity and the number of laboratory biomarkers of lymphopenia, inflammation [i.e., CRP, procalcitonin], and organ function measures [i.e., AST, ALT or creatinine) on admission in both cohorts (Supplementary Tables S2, S3).